April 2019 FDA Recall Drug by American Health Packaging
D-1276-2019 - Failed Dissolution Specifications

This Class II drug recall was voluntarily initiated by American Health Packaging on April 8, 2019 for the product Drug. The FDA reported the reason for recall as failed dissolution specifications. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-1276-2019

Reason for Recall
Failed Dissolution Specifications: dissolution failure at time zero of the repackaged lot. Drug release results were slightly above specification at time zero.
Initiated
04-08-2019
Reported
05-08-2019
Quantity
2,203 cartons (cartons of 30 individual unit doses)

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
American Health Packaging
Nationwide in the USA
GlipiZIDE Extended-release Tablets, 2.5 mg, 30 Tablets (3 x 10), Rx Only, Packaged and Distributed by: American Health Packaging, Columbus, Ohio 43217. NDC: 68084-295-21

Batch or Lot Expiration Information

Lot# 181288, EXP 5/31/2020